Focal adhesion kinase: a promising target for anticancer therapy

Bibliography

• SCHALLER MD, BORGMAN CA, COBB BS et al.: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA (1992) 89:5192-5196.
   PubMed Web of Science ®Google Scholar
• GUAN JL, SHALLOWAY D: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation: Nature (1992) 358:690-692.
   PubMed Web of Science ®Google Scholar
• SCHLAEPFER DD, HAUCK CR, STIEG DJ: Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. (1999) 71:435-478.
   PubMed Web of Science ®Google Scholar
• ZACHARY I: Focal adhesion kinase. Int. J. Biochem. Cell Biol. (1997) 29:929-934.
   PubMedGoogle Scholar
• CARY LA, GUAN JL: Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. (1999) 4:D102-D113.
   PubMedGoogle Scholar
• SCHALLER MD, PARSONS JT: Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. (1994) 6:705-710.
   PubMed Web of Science ®Google Scholar
• SCHLAEPFER DD, MITRA SK, ILIC D: Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta (2004) 1692:77-102.
   PubMed Web of Science ®Google Scholar
• MANES S, MIRA E, GOMEZ-MOUTON C, ZHAO ZJ, LACALLE RA, MARTINEZ-A C: Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell Biol. (1999) 19:3125-3135.
   PubMed Web of Science ®Google Scholar
• WANG FM, LIU HQ, LIU SR et al.: SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1β in vivo and in vitro. Breast Cancer Res. Treat. (2005) 89:5-14.
   PubMedGoogle Scholar
• VADLAMUDI RK, ADAM L, NGUYEN D et al.: Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2. J. Cell Physiol. (2002) 190:189-199.
   PubMedGoogle Scholar
• TAMURA M, GU J, TRAN H et al.: PTEN gene and integrin signaling in cancer. J. Natl. Cancer Inst. (1999) 91:1820-1828.
   PubMedGoogle Scholar
• ZHANG L, YU Q, HE J et al.: Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines. Mol. Cell Biochem. (2004) 262:25-33.
   PubMedGoogle Scholar
• COX BD, NATARAJAN M, STETTNER MR et al.: New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell Biochem. (2006) 99:35-52.
   PubMed Web of Science ®Google Scholar
• TSAI YT, SU YH, FANG SS et al.: Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol. Cell Biol. (2000) 20:2043-2054.
   PubMed Web of Science ®Google Scholar
• CHEN R, KIM O, LI M et al.: Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat. Cell Biol. (2001) 3:439-444.
   PubMed Web of Science ®Google Scholar
• SAWHNEY RS, COOKSON MM, OMAR Y et al.: Integrin α2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J. Biol. Chem. (2006) 281:8497-8510.
   PubMedGoogle Scholar
• SHETA EA, HARDING MA, CONAWAY MR et al.: Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor. J. Natl. Cancer Inst. (2000) 92:1065-1073.
   PubMedGoogle Scholar
• MITRA SK, SCHLAEPFER DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. (2006) 18:516-523.
   PubMed Web of Science ®Google Scholar
• HU B, JARZYNKA MJ, GUO P et al.: Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the avb1 integrin and focal adhesion kinase signaling pathway. Cancer Res. (2006) 66:775-783.
   PubMed Web of Science ®Google Scholar
• ZENG ZZ, LIA Y, HAHN NJ et al.: Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res. (2006) 66:8091-8099.
   PubMed Web of Science ®Google Scholar
• VAN NIMWEGEN MJ, VAN DE WATER B: Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. (2007) 73:597-609.
   PubMedGoogle Scholar
• GUAN JL: Role of focal adhesion kinase in integrin signaling. Int. J. Biochem. Cell Biol. (1997) 29:1085-1096.
   PubMed Web of Science ®Google Scholar
• WESTHOFF MA, SERRELS B, FINCHAM VJ et al.: SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol. Cell Biol. (2004) 24:8113-8133.
   PubMed Web of Science ®Google Scholar
• BRUTON VG, MACPHERSON IRJ, FRAME MC: Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim. Biophys. Acta (2004) 1692:121-144.
   PubMedGoogle Scholar
• CHANG F, LEMMON CA, PARK D et al.: FAK potentiates Rac1 activation and localization to MATRIX ADHESION SITES: a role for {β}PIX. Mol. Biol. Cell. (2007) 18(1):253-264.
   PubMedGoogle Scholar
• BROWN MC, CARY LA, JAMIESON JS et al.: Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization and regulate cell spreading and protrusiveness. Mol. Biol. Cell (2005) 19:4316-4328.
   Google Scholar
• HOOD JD, FRAUSTO R, KIOSSES WB et al.: Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J. Cell Biol. (2003) 162:933-943.
   PubMed Web of Science ®Google Scholar
• ALMEIDA EA, ILIC D, HAN Q et al.: Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. (2000) 149:741-754.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI R, SONODA Y, ICHIKAWA D et al.: Focal adhesion kinase determines the fate of death or survival of cells in response to TNF-α in the presence of actinomycin D. Biochim. Biophys. Acta (2007) 1770:518-526.
   PubMedGoogle Scholar
• WANG WJ, KUO JC, YAO CC, CHEN RH: DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J. Cell Biol. (2002) 159:169-179.
   PubMed Web of Science ®Google Scholar
• BRYANT P, ZHENG Q, PUMIGLIA K: Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Mol. Cell Biol. (2006) 26:4201-4213.
   PubMedGoogle Scholar
• GARCES CA, KURENOVA EV, GOLUBOVSKAYA VM et al.: Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res. (2006) 66:1446-1454.
   PubMed Web of Science ®Google Scholar
• JONES G, MACHADO J Jr, MERLO A: Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res. (2001) 61:4978-4981.
   PubMedGoogle Scholar
• JONES G, MACHADO J Jr, TOLNAY M, MERLO A: PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res. (2001) 61:5688-5691.
   PubMed Web of Science ®Google Scholar
• VAN NIMWEGEN MJ, VERKOEIJEN S, VAN BUREN L et al.: Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. (2005) 65:4698-4706.
   PubMedGoogle Scholar
• HANADA M, TANAKA K, MATSUMOTO Y et al.: Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis. Clin. Exp. Metast. (2005) 22:485-494.
   PubMed Web of Science ®Google Scholar
• HESS AR, HENDRIX MJC: Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle (2006) 5:478-480.
   PubMed Web of Science ®Google Scholar
• HAUCK CR, HSIA DA, PUENTE XS et al.: FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. (2002) 21:6289-62302.
   PubMedGoogle Scholar
• HESS AR, POSTOVIT LM, MARARYAN NV et al.: Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res. (2005) 65:9851-9860.
   PubMed Web of Science ®Google Scholar
• YANG J, PRICE MA, NEUDAUER CL et al.: Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms. J. Cell Biol. (2004) 165:881-891.
   PubMed Web of Science ®Google Scholar
• SOOD AK, COFFIN JE, SCHNEIDER GB et al.: Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am. J. Pathol. (2004) 165:1087-1095.
   PubMed Web of Science ®Google Scholar
• ZHENG DQ, WOODARD AS, FORNARO M et al.: Prostatic carcinoma cell migration via α(v)β3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res. (1999) 59:1655-1664.
   PubMed Web of Science ®Google Scholar
• LACOSTE J, APRIKIAN AG, CHEVALIER S: Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility. Mol. Cell Endocrinol. (2005) 235:51-61.
   PubMedGoogle Scholar
• HASKELL H, NATARAJAN M, HECKER TP et al.: Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin. Cancer Res. (2003) 9:2157-2165.
   PubMed Web of Science ®Google Scholar
• EARLEY S, PLOPPER E: Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells. Biochem. Biophys. Res. Commun. (2006) 350:405-412.
   PubMed Web of Science ®Google Scholar
• ABDEL-GHANY M, CHENG HC, ELBLE RC et al.: Focal adhesion kinase activated by β(4) integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem. (2002) 277:34391-34400.
   PubMed Web of Science ®Google Scholar
• GOLUBOVSKAYA VM, GROSS S, KAUR AS et al.: Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. (2003) 1:755-764.
   PubMed Web of Science ®Google Scholar
• THAMILSELVAN V, BASSON MD: Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling. Gastroenterology (2004) 126:8-18.
   PubMed Web of Science ®Google Scholar
• MON NN, HASEGAWA H, THANT AA et al.: A role for focal adhesion kinase signaling in TNF-α-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res. (2006) 66:6778-6784.
   PubMed Web of Science ®Google Scholar
• HUANG YT, LEE LT, LEE PPH et al.: Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. Anticancer Res. (2005) 25:2017-2025.
   PubMed Web of Science ®Google Scholar
• DUXBURY MS, ITO H, ZINNER MJ et al.: Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery (2004) 135:555-562.
   PubMed Web of Science ®Google Scholar
• HAN EK, MCGONIGAL T, WANG J et al.: Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs. Anticancer Res. (2004) 24:3899-3905.
   PubMedGoogle Scholar
• SHIBATA K, KIKKAWA F, NAWA A et al.: Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. (1998) 58:900-903.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, THANT AA, HIRAIWA Y et al.: A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem. Biophys. Res. Commun. (2002) 290:1123-1127.
   PubMedGoogle Scholar
• ZHANG Y, LU H, DAZIN P et al.: Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin αv mediate survival signals through focal adhesion kinase. J. Biol. Chem. (2004) 279:48342-48349.
   PubMedGoogle Scholar
• GU Y, CHEN JS, ZHOU XD: Inhibitory effects of antisense focal adhesion kinase oligodeoxynucleotides on the invasion of Bel 7402 hepatocellular carcinoma cells. Zhonghua Gan Zang Bing Za Zhi (2003) 11:612-615.
   PubMedGoogle Scholar
• YU HG, TONG SL, DING YM et al.: Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. Int. J. Cancer (2006) 119:2724-2732.
   PubMedGoogle Scholar
• FANG Y, FANG X, WANG L: Influence of focal adhesion kinase (FAK) on the biological behaviors of human hepatocellular carcinoma cells. Zhonghua Zhong Liu Za Zhi (2001) 23:125-127.
   PubMedGoogle Scholar
• GUAN GX, JIAN HX, LEI DY et al.: Construction of retroviral vector of p(125FAK) specific ribozyme genes and its effects on BGC-823 cells. World J. Gastroenterol. (2006) 12:686-690.
   PubMedGoogle Scholar
• SHINTANI S, LI C, MIHARA M et al.: Gefitinib (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett. (2003) 201:149-155.
   PubMed Web of Science ®Google Scholar
• LIU Y, KYLE E, LIEBERMAN R et al.: Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-β-1-integrin complex formation. Clin. Exp. Metast. (2000) 18:203-212.
   PubMedGoogle Scholar
• CHIOREAN MV, GUICCIARDI ME, YOON JH et al.: Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells. Liver Int. (2004) 24:687-695.
   PubMedGoogle Scholar
• MATSUMOTO K, MATSUMOTO K, NAKAMURA T et al.: Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. (1994) 269:31807-31813.
   PubMed Web of Science ®Google Scholar
• SLACK-DAVIS JK, MARTIN KH, TILGHMAN RW et al.: Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. (2007) 282:14845-14852.
   PubMed Web of Science ®Google Scholar
• SHI Q, HJELMELAND AB, KEIR ST et al.: A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol. Carcinog. (2007) 46:488-496.
   PubMed Web of Science ®Google Scholar
• LIU TJ, LAFORTUNE T, HONDA T et al.: Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol. Cancer Ther. (2007) 6:1357-1367.
   PubMed Web of Science ®Google Scholar
• SIU LL, BURRIS HA, MILESHKIN L et al.: Phase 1 study of a focal adhesion kinase (FAK) inhibitor PF-00562271 in patients (pts) with advanced solid tumors. J. Clin. Oncol., 2007 ASCO Annual Meeting Proceedings (2007) 25:3527.
   Google Scholar
• RASO E, TOVARI J, LADANYI A et al.: Ligand-mimetic anti-αIIb β3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells. Pathol. Oncol. Res. (2005) 11:218-223.
   PubMedGoogle Scholar
• AIXINJUELUO W, FURUKAWA K, ZHANG Q et al.: Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis. J. Biol. Chem. (2005) 280:29828-29836.
   PubMed Web of Science ®Google Scholar
• MELKOUMIAN ZK, PENG X, GAN B et al.: Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res. (2005) 65:6676-6684.
   PubMedGoogle Scholar
• CHANO T, IKEGAWA S, KONTANI K et al.: Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene (2002) 21:1295-1298.
   PubMedGoogle Scholar
• KATO R, ISHIKAWA T, KAMIYA S et al.: A new type of antimetastatic peptide derived from fibronectin. Clin. Cancer Res. (2002) 8:2455-2462.
   PubMed Web of Science ®Google Scholar
• NAKAHARA S, MIYOSHI E, NODA K et al.: Involvement of oligosaccharide changes in α5b1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol. Cancer Ther. (2003) 2:1207-1214.
   PubMed Web of Science ®Google Scholar
• VILLEDIEU M, DESLANDES E, DUVAL M et al.: Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment. Gynecol. Oncol. (2006) 101:507-519.
   PubMedGoogle Scholar
• RECHER C, YSEBAERT L, BEYNE-RAUZY O et al.: Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res. (2004) 64:3191-3197.
   PubMed Web of Science ®Google Scholar
• SASAKI H, KOTSUJI F, TSANG BK: Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein. Gynecol. Oncol. (2002) 85:339-350.
   PubMedGoogle Scholar
• HALDER J, LANDEN CN JR, LUDGENDORF SK et al.: Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin. Cancer Res. (2005) 11:8829-8836.
   PubMed Web of Science ®Google Scholar
• ADDADI-REBBAH S, POLITEVIN S, FOURRE N et al.: Assessment of the antiinvasive potential of the anthracycline aclacinomycin (Aclarubicin) in a human fibrosarcoma cell line. Int. J. Oncol. (2004) 24:1607-1615.
   PubMedGoogle Scholar
• VAN NIMWEGEN MJ, HUIGSLOOT M, CAMIER A et al.: Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. Mol. Pharmacol. (2006) 70:1330-1339.
   PubMedGoogle Scholar
• CHANG X, LIU XL, DU QF et al.: Study of adhesion-related molecule β1-integrin and focal adhesion kinase in chronic myeloid leukemia. Di Yi Jun Yi Da Xue Xue Bao (2003) 23:1047-1049.
   PubMedGoogle Scholar
• WU ZM, YUAN XH, JIANG PC et al.: Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells. J. Neurooncol. (2006) 77:117-123.
   PubMed Web of Science ®Google Scholar
• KORNBERG LJ: Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells. Anticancer Res. (2005) 25:4349-4356.
   PubMedGoogle Scholar
• FANG Y, WANG L, JIN J et al.: Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to TNF-α/cycloheximide-induced apoptosis by regulating protein kinase B levels. Eur. J. Biochem. (2001) 268:4513-4519.
   PubMedGoogle Scholar
• DUXBURY MS, ITO H, BENOIT E et al.: RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. (2003) 311:786-792.
   PubMed Web of Science ®Google Scholar
• HALDER J, KAMAT AA, LANDEN CN Jr et al.: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. (2006) 12:4916-4924.
   PubMed Web of Science ®Google Scholar
• SMITH CS, GOLUBOVSKAYA VM, PECK E et al.: Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. Melanoma Res. (2005) 15:357-362.
   PubMed Web of Science ®Google Scholar
• BEINKE C, VAN BEUNINGEN D, CORDES N: Ionizing radiation modules of the expression and tyrosine phosphorylation of the focal adhesion-associated proteins focal adhesion kinase (FAK) and its substrates p130cas and paxillin in A549 human lung carcinoma cells in vitro. Int. J. Radiat. Biol. (2003) 79:721-731.
   PubMed Web of Science ®Google Scholar
• DE BELLE I, HUANG RP, FAN Y et al.: p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene (1999) 18:3633-3642.
   PubMedGoogle Scholar
• CHUNG YM, KIM BG, PARK CS et al.: Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int. J. Cancer (2005) 117:194-201.
   PubMed Web of Science ®Google Scholar
• KASAHARA T, KOGUCHI E, FUNAKOSHI M et al.: Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Antioxid. Redox Signal. (2002) 4:491-499.
   PubMed Web of Science ®Google Scholar
• PLANAS-SILVA MD, BRUGGEMAN RD, GRENKO RT et al.: Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem. Biophys. Res. Commun. (2006) 341:73-81.
   PubMed Web of Science ®Google Scholar
• HISCOX S, JORDAN NJ, MORGAN L, GREEN TP, NICHOLSON RI: Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin. Exp. Metast. (2007) 24:157-167.
   PubMedGoogle Scholar
• BARTHOLOMEW PJ, VINCI JM, DEPASQUALE JA: Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells. J. Steroid Biochem. Mol. Biol. (1998) 67:241-249.
   PubMedGoogle Scholar
• SONG RX, ZHANG Z, CHEN Y, BAO Y, SANTEN RJ: Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology (2007) 148:4091-4101.
   PubMed Web of Science ®Google Scholar
• MCLEAN GW, BROWN K, ARBUCKLE MI et al.: Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res. (2001) 61:8385-8389.
   PubMedGoogle Scholar
• MCLEAN GW, KOMIYAMA NH, SERRELS B et al.: Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev. (2004) 18:2998-3003.
   PubMed Web of Science ®Google Scholar
• CHEN Y, WANG SM, WU JC et al.: Effects of PPARγ agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line. J. Cell Biochem. (2006) 98:1021-1035.
   PubMedGoogle Scholar
• TAMURA M, GU J, DANAN EHJ et al.: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. (1999) 274:20693-20703.
   PubMed Web of Science ®Google Scholar
• TAMURA M, GU J, MATSUMOTO K et al.: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (1998) 280:1614-1617.
   PubMed Web of Science ®Google Scholar
• GU J, TAMURA M, YAMADA KM: Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol. (1998) 143:1375-1383.
   PubMed Web of Science ®Google Scholar
• TAMURA M, GU J, TAKINO T et al.: Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res. (1999) 59:442-449.
   PubMed Web of Science ®Google Scholar
• HAIER J, NICOLSON GL: PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene (2002) 21:1450-1460.
   PubMed Web of Science ®Google Scholar
• YANG ZF, YI JL, LI XR et al.: PTEN induces apoptosis and up-regulates p53 expression in HepG2 cells. Zhonghua Gan Zang Bing Za Zhi (2004) 12:745-748.
   PubMedGoogle Scholar
• CHEN QY, WANG CY, WU HS et al.: Exogenous PTEN gene induces apoptosis in breast cancer cells. Zhonghua Yi Xue Za Zhi (2005) 85:33-36.
   PubMedGoogle Scholar
• MAIER D, JONES G, LI X et al.: The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. (1999) 59:5479-5482.
   PubMed Web of Science ®Google Scholar
• GAUTAM A, LI ZR, BEPLER G: RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene (2003) 22:2135-2142.
   PubMed Web of Science ®Google Scholar
• MHASHILKAR AM, STEWART AL, SIEGER K et al.: MDA-7 negatively regulates the β-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther. (2003) 8:207-219.
   PubMed Web of Science ®Google Scholar